P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLCA. Horne, A. Greystoke, Adam Hassani et al.|Journal of Thoracic Oncology|2023Cited by 2
77P Experience pooling control arms within a complex phase I drug-radiotherapy (RT) platform trialJamie B. Oughton, Sarah Brown, J. Kendall et al.|ESMO Open|2024Cited by 0